Menstrual Irregularities and Amenorrhea in Thyroid Eye Disease Patients Treated With Teprotumumab

20247 citationsJournal Article

Authors

Anna K. Terrarosa · City University of New York

Lauren N. DeMaria · City University of New York

Victoria S. North · Tufts Medical Center

María Dolores Aguilar García · City University of New York

Eleanore T. Kim · City University of New York

Irina Belinsky · City University of New York

Abstract

Abnormalities of menstruation, including amenorrhea, were reported by 75% of patients treated with teprotumumab. These changes reverted to baseline after treatment in most affected patients.

Topics & Keywords

Ophthalmology and Eye Disorders Pituitary Gland Disorders and Treatments Cerebral Venous Sinus Thrombosis

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Ophthalmic Plastic and Reconstructive Surgery

Volume 40, Issue 3, pp. 312-315

DOI: 10.1097/iop.0000000000002569

Field-Weighted Citation Impact: 3.15